|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (as glyburide, 1984)) |
IUPAC Name ![]() |
| 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 2386 | glibenclamide |
Synonyms ![]() |
| Diabeta® |
| glyburide |
| Glynase® |
Database Links ![]() |
|
| BindingDB Ligand | 50012957 |
| CAS Registry No. | 10238-21-8 |
| ChEBI | CHEBI:5441 |
| ChEMBL Ligand | CHEMBL472 |
| DrugBank Ligand | DB01016 |
| PharmGKB Drug | PA449782 |
| PubChem CID | 3488 |
| RCSB PDB Ligand | GBM |
| Search Google for chemical match using the InChIKey | ZNNLBTZKUZBEKO-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | ZNNLBTZKUZBEKO |
| Search PubMed clinical trials | glibenclamide |
| Search PubMed titles | glibenclamide |
| Search PubMed titles/abstracts | glibenclamide |
| Wikipedia | Glibenclamide |
| Comments |
| A sulfonylurea family drug inhibiting sulfonylurea receptor 1 (ABCC8)/Kir6.2 (KCNJ11) |